论文部分内容阅读
来自《Med Ad News》的一份年度分析报告指出,2010年值得期待的重磅炸弹药物涉及一系列疾病领域,包括:心血管系统疾病、自身免疫系统疾病、呼吸系统疾病以及代谢紊乱症等。五大潜力产品有望于2010年获批上市,预计每个产品的销售额均有望达到10亿美元以上,成为未来的重磅炸弹药物。
An annual report from Med Ad News points out that the anticipated 2010 blockbuster drugs cover a range of disease areas, including cardiovascular system diseases, autoimmune system diseases, respiratory diseases and metabolic disorders. Five potential products are expected to be approved in 2010, and the sales of each product are expected to reach more than 1 billion U.S. dollars, becoming the future blockbuster drug.